The Inhibitory Effect of S-777469, a Cannabinoid Type 2 Receptor Agonist, on Skin Inflammation in Mice

By  

Pharmacology, Vol. 99, Iss. 5-6, 2017-02 ,pp. : 259-267

Karger

Access to resources Recommend Favorite

Celastrol Attenuates Inflammatory and Neuropathic Pain Mediated by Cannabinoid Receptor Type 2

By Yang Longhe   Li Yanting   Ren Jie   Zhu Chenggang   Fu Jin   Lin Donghai   Qiu Yan  

International Journal of Molecular Sciences, Vol. 15, Iss. 8, 2014-08 ,pp. : 13637-13648

MDPI

Access to resources Recommend Favorite

12-Lipoxygenase Inhibition on Microalbuminuria in Type-1 and Type-2 Diabetes Is Associated with Changes of Glomerular Angiotensin II Type 1 Receptor Related to Insulin Resistance

By Xu Hong-Zhao   Cheng Yan-Li   Wang Wan-Ning   Wu Hao   Zhang Yuan-Yuan   Zang Chong-Sen   Xu Zhong-Gao  

International Journal of Molecular Sciences, Vol. 17, Iss. 5, 2016-05 ,pp. : 684-684

MDPI

Access to resources Recommend Favorite

A Novel Role of Serotonin Receptor 2B Agonist as an Anti-Melanogenesis Agent

By Oh Eun Ju   Park Jong Il   Lee Ji Eun   Myung Cheol Hwan   Kim Su Yeon   Chang Sung Eun   Hwang Jae Sung  

International Journal of Molecular Sciences, Vol. 17, Iss. 4, 2016-04 ,pp. : 546-546

MDPI

Access to resources Recommend Favorite

Synthesis and Preliminary Evaluation of a 2-Oxoquinoline Carboxylic Acid Derivative for PET Imaging the Cannabinoid Type 2 Receptor

By Mu Linjing   Slavik Roger   Müller Adrienne   Popaj Kasim   Čermak Stjepko   Weber Markus   Schibli Roger   Krämer Stefanie D.   Ametamey Simon M.  

Pharmaceuticals, Vol. 7, Iss. 3, 2014-03 ,pp. : 339-352

MDPI

Access to resources Recommend Favorite